NWBO enters $15M loan with Streeterville; conversion right tied to Phase III data

NORTHWEST BIOTHERAPEUTICS INC

Net proceeds of $15M from Streeterville Capital, LLC; 22-month maturity, 8% interest, 10% OID.
No payments first 8 months, then 14 equal monthly principal installments at 110% pro rata plus interest.
Lender gets springing right upon top-line data from DCVax-L Phase III to convert balance into shares at 12% discount to next private placement.
Funds will be used for ongoing business operations.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.